Medicina nuclear e Imagen molecular
INFORMACIÓN DE CONTACTO
Grupo de Investigación
ARBIZU LOSTAO, JAVIER
Correo Electrónico
jarbizu@unav.es
Ayerra, L, Abellanas, MA, Vidaurre, C, Basurco, L, Tavira, A, Luquin, E, Clavero, P, Mengual, E, Collantes, M, Peñuelas, I, Martin-Esteban, SRD, Grether, U, Hillard, CJ, Romero, J, Hervás-Stubbs, S, Aymerich, MS
"Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease".
Brain Behav. Immun.. 128: 600 - 611. 2025. [doi:10.1016/j.bbi.2025.04.037]
Pinto, E, Rodriguez-Fraile, M, Cabrera, A, Rodriguez, LS, Llopiz, D, Ruiz, M, Silva, L, Matilla, A, Varela, M, Reig, M, de la Torre, M, Argemi, J, Hervás-Stubbs, S, Sarobe, P, Sangro, B
"The dose of radiation absorbed by the tumor and the non-tumoral compartments does not impact peripheral immune markers after SIRT".
J. Hepatol.. 82: 485 - 486. 2025.
Martínez-Francés, E, Morán, V, Méndez, R, Domingo, C, Romero, AM, Martí-Climent, JM
"Neutron detectors in proton therapy: Calibration, operational in situ verification, and comparison with Monte Carlo simulation".
Radiat. Phys. Chem.. 228: 112362. 2025. [doi:10.1016/j.radphyschem.2024.112362]
Rosales JJ, Betech Antar V, Mínguez F, Pareja F, Guillén F, Prieto E, Quincoces G, Caballero FD, Miñana B, Pérez-Gracia JL, Rodríguez-Fraile M
"Comparison of staging using [(68)Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection.".
Rev Esp Med Nucl Imagen Mol (Engl Ed). 44(2): 500076 - 500076. 2025. [doi:10.1016/j.remnie.2024.500076]
Martín-Otal, C, Sánchez-Moreno, I, Gómez-Morón, A, Castro, C, Casares, N, Navarro, F, Gorraiz, M, Justicia-Lirio, P, Pareja, F, Collantes, M, Peñuelas, I, Iñarrairaegui, M, Sangro, B, Vivas, I, Larrayoz, M, Rodriguez, JR, Prosper, F, Hervas-Stubbs, S, Martin-Cofreces, N, Lasarte, JJ, Lozano, T
"Phosphatidylserine as a tumor target for CAR-T cell therapy".
J. Immunother. Cancer. 13(2): e009468. 2025. [doi:10.1136/jitc-2024-009468]
Garate-Soraluze, E, Serrano-Mendioroz, I, Fernández-Rubio, L, de Andrea, CE, Barrio-Alonso, C, Herrero, CD, Teijeira, A, Luri-Rey, C, Claus, C, Tanos, T, Klein, C, Umana, P, Rullan, A, Simón, JA, Collantes, M, Sánchez-Mateos, P, Melero, I, Rodriguez-Ruiz, ME
"4-1BB agonist targeted to fibroblast activation protein a synergizes with radiotherapy to treat murine breast tumor models".
J. Immunother. Cancer. 13(1): e009852. 2025. [doi:10.1136/jitc-2024-009852]
Durán-Lobato, M, Tovar, S, Cuñarro, J, Ramos-Membrive, R, Peñuelas, I, Marigo, I, Benetti, F, Chenlo, M, Alvarez, C, Ildikó, V, Urbanics, R, Szebeni, J, Alonso, MJ
"Bioinspired orthogonal-shaped protein-biometal nanocrystals enable oral protein absorption.".
J. Control. Release. 377: 17 - 36. 2025. [doi:10.1016/j.jconrel.2024.11.016]
Hernandez-Osuna, R, Lacalle, A, Gonzalez-Huarriz, M, Marco-Sainz, J, Palacios, D, Nuin, S, Morales, S, Perez-Larraya, JG, Patiño-García, A, Phoenix, T, Hernandez-Lain, A, Lassaletta, A, Blasco, L, Quincoces, G, Collantes, M, Solano, P, Alonso, MM, Labiano, S
"DEVELOPMENT AND CHARACTERIZATION OF A SPINAL CORD DIFFUSE MIDLINE GLIOMA MODEL".
Neuro-Oncology. 26. 2024. [doi:10.1093/neuonc/noae165.1271]
|